Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Sanofi Should Be Thinking Longer Duration In GLP-1s
Sanofi Should Be Thinking Longer Duration In GLP-1s
Sanofi Should Be Thinking Longer Duration In GLP-1s
Submitted by
admin
on August 2, 2016 - 9:09am
Source:
Seeking Alpha
News Tags:
Sanofi
GLP-1 agonist
Adlyxin
Headline:
Sanofi Should Be Thinking Longer Duration In GLP-1s
Do Not Allow Advertisers to Use My Personal information
